Inventor · disambiguated record
Eldad Melamed
Also filed as: MELAMED ELDAD
25 granted patents·10 pending applications·432 citations·filing 1992–2022
96Inventor score
Top patents by PatentIndex Score
35 records- 0186US5840756APharmaceutical composition of L-DOPA esterTEVA PHARMA·Filed 1996·Granted Nov 24, 1998·98 cites·16 claims
- 0284US8647874B2Isolated cells and populations comprising same for the treatment of CNS diseasesOFFEN DANIEL·Filed 2007·Granted Feb 11, 2014·5 cites·14 claims
- 0384US6369106B1Treatment of ischemic brain injuries with brain targeted anti oxidant compoundsYISSUM RES DEV CO·Filed 1999·Granted Apr 9, 2002·62 cites·8 claims
- 0484US5607969AL-DOPA ethyl ester to treat Parkinson's diseaseYISSUM RES DEV CO·Filed 1995·Granted Mar 4, 1997·80 cites·22 claims
- 0583US8900574B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2014·Granted Dec 2, 2014·5 cites·4 claims
- 0683US8663987B2Mesenchymal stem cells for the treatment of CNS diseasesKADOURI AVINOAM·Filed 2009·Granted Mar 4, 2014·9 cites·6 claims
- 0782US9474787B2Mesenchymal stem cells for the treatment of CNS diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2014·Granted Oct 25, 2016·4 cites·5 claims
- 0876US6420429B1Brain targeted low molecular weight hydrophobic antioxidant compoundsYISSUM RES DEV CO·Filed 1999·Granted Jul 16, 2002·38 cites·8 claims
- 0974US10052363B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2016·Granted Aug 21, 2018·1 cites·7 claims
- 1074US9717761B2Stem cell-derived neural cells for cell therapy in neurological disordersRAMOT AT TEL-AVIV UNIV LTD·Filed 2012·Granted Aug 1, 2017·3 cites·10 claims
- 1173US5354885AProcess for preparing ethyl ester of L-DOPAYISSUM RES DEV CO·Filed 1992·Granted Oct 11, 1994·42 cites·4 claims
- 1270US11185572B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2018·Granted Nov 30, 2021·0 cites·5 claims
- 1370US8378070B2Peptides for the regulation of neurotransmitter sequestration and releaseUNIV RAMOT·Filed 2008·Granted Feb 19, 2013·0 cites·6 claims
- 1469US9879225B2Isolated cells and populations comprising same for the treatment of CNS diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2014·Granted Jan 30, 2018·0 cites·3 claims
- 1569US5874468ABrain targeted low molecular weight hydrophobic antioxidant compoundsYISSUM·Filed 1996·Granted Feb 23, 1999·45 cites·11 claims
- 1667US9023800B2Peptides for the treatment of oxidative stress related disordersOFFEN DANIEL·Filed 2012·Granted May 5, 2015·1 cites·2 claims
- 1767US8212001B2Peptides for the treatment of oxidative stress related disordersOFFEN DANIEL·Filed 2010·Granted Jul 3, 2012·1 cites·5 claims
- 1866US10869899B2Isolated cells and populations comprising same for the treatment of CNS diseasesUNIV RAMOT·Filed 2017·Granted Dec 22, 2020·0 cites·10 claims
- 1965US10744162B2Genetically modified muscle cells which express neurotrophic factorsRAMOT AT TEL-AVIV UNIV LTD·Filed 2019·Granted Aug 18, 2020·0 cites·4 claims
- 2063US5525631ACompositions of the ethyl ester of L-DOPAYISSUM RES DEV CO·Filed 1994·Granted Jun 11, 1996·24 cites·20 claims
- 2162US12067791B2Method and system for roads' maintenanceINUITIVE LTD·Filed 2022·Granted Aug 20, 2024·0 cites·7 claims
- 2259US7280594B2Method and apparatus for motion estimation in a sequence of digital imagesPARTHUSEEVA LTD·Filed 2002·Granted Oct 9, 2007·7 cites·11 claims
- 2354US2009257987A1Method of generating dopamine-secreting cellsUNIV RAMOT·Filed 2009·Application pending·0 cites
- 2454US2002107176A1Brain targeted low molecular weight hydrophobic anti oxidant compoundsFiled 2002·Application pending·0 cites
- 2553US2013236964A1Methods, nucleic acid constructs and cells for treating neurodegenerative disordersUNIV RAMOT·Filed 2013·Application pending·0 cites
- 2651US9365828B2Genetically modified muscle cells which express neurotrophic factorsOFFEN DANIEL·Filed 2012·Granted Jun 14, 2016·0 cites·2 claims
- 2751US2003083266A1Treatment of ischemic brain injuries with brain targeted antioxidant compoundsFiled 2000·Application pending·0 cites
- 2849US2016279169A1Genetically modified muscle cells which express neurotrophic factorsRAMOT AT TEL-AVIV UNIV LTD·Filed 2016·Application pending·0 cites
- 2948US2010021434A1Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS DiseasesUNIV RAMOT·Filed 2006·Application pending·0 cites
- 3047US2006211628A1Treatment of multiple sclerosis with brain targeted anti oxidant compoundsATLAS DAPHNE·Filed 2003·Application pending·0 cites
- 3146US2013123187A1Peptides for the regulation of neurotransmitter sequestration and releaseUNIV RAMOT·Filed 2012·Application pending·0 cites
- 3245US2004235747A1Methods of treating and/or preventing autoimmune diseasesUNIV RAMOT·Filed 2003·Application pending·0 cites
- 3344US2005265983A1Methods, nucleic acid constructs and cells for treating neurodegenerative disordersMELAMED ELDAD·Filed 2005·Application pending·0 cites
- 3440US8213502B2Method and system for real-time adaptive quantization controlMELAMED ELDAD·Filed 2007·Granted Jul 3, 2012·0 cites·23 claims
- 3539US6417210B1Treatment of dyskinesias and Parkinson's disease with riluzole and levodopaMOR RESEARCH APPLIC LTD·Filed 1999·Granted Jul 9, 2002·7 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Eldad Melamed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →